Arthritis and Heart Disease
People with RA face a 50 percent higher risk for cardiovascular disease. They are significantly more likely to have a heart attack and more likely to be hospitalized for heart failure. Learn more.
Chronic Inflammation and Your Heart
“Inflammation, regardless of where it comes from, is a risk factor for heart disease,” says rheumatologist Jon T. Giles, MD, assistant professor of medicine at Columbia University School of Medicine. “So it’s not surprising that people with inflammatory arthritis like RA, lupus, and psoriatic arthritis have more cardiac events.”
Inflammatory cells get into blood vessel walls where they make cytokines – immune system proteins that promote inflammation. Inflammation also reshapes blood-vessel walls, making deposited plaques more prone to rupture. A rupture, in turn, can trigger a heart attack.
The risk isn’t limited to people with inflammatory arthritis. Although OA is not in itself inflammatory, its damage can cause inflammation, which in turn increases the risk of heart disease.
Work with your rheumatologist to get arthritis under control and ensure you have the lowest amount of systemic inflammation possible. A large study in the 2017 Annals of the Rheumatic Diseases found that people with RA who had their disease well-controlled were less likely to develop cardiovascular disease.
One of the best ways to manage your disease is with medication. Some, but not all, arthritis drugs will help you avoid heart problems.
Arthritis Drugs and Your Heart
A few of the drugs you take to manage joint pain can also protect your heart. Most disease-modifying anti-rheumatic drugs (DMARDs) – including methotrexate, sulfasalazine (Azulfidine), and hydroxychloroquine (Plaquenil) – appear to have a protective effect. Tumor necrosis factor inhibitors (TNF inhibitors) such as adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade), also protect the heart by reducing inflammation in the body.
On the flip side, other arthritis drugs actually harm the heart. NSAIDs have become notorious for increasing the risk for heart attack or stroke. In 2018, the FDA issued a stern warning about these drugs, cautioning that they can lead to heart events within just a few weeks of use. The risk increases the longer you take them and the higher dose you use. If you do take an NSAID, use the smallest possible amount for the shortest period of time needed to manage your symptoms.
Also risky is the steroid drug, prednisone. Though it works by lowering inflammation, prednisone can also raise blood pressure, increase cholesterol levels, and harden the arteries. If you have to take steroids, balance your desire for arthritis relief with the need to protect your heart.
Lifestyle Factors and Your Heart
Having arthritis alone doesn’t destine you to develop heart disease. Lifestyle factors like obesity, high blood pressure, diabetes and high cholesterol also play into your chances. These factors often overlap in people with arthritis. According to the Centers for Disease Control and Prevention (CDC), 47 percent of people with diabetes have arthritis, as well as 31 percent of those who are obese. And nearly half of all adults with heart disease also have arthritis.
Smoking is a heart disease risk factor, too. It raises blood pressure, lowers HDL (“good” cholesterol), and speeds plaque buildup in arteries. No matter how long you’ve smoked, it’s never too late to quit. Medications, nicotine-replacement products, and counseling can all help speed your transition off cigarettes.
Diet and exercise can help you lose weight, lower blood pressure and cholesterol, and manage diabetes. Yet exercising can be especially difficult for those with OA who are overweight or obese. It’s a vicious cycle: You’re in pain, so you don’t exercise. Not exercising means your joints hurt even more. To overcome these obstacles, find a fitness program that suits your abilities, get your doctor’s advice, and start slowly.
- People with RA have a 50-70 percent higher risk for cardiovascular disease than the general population.
- People with OA face a 24 percent higher risk for cardiovascular disease than the general population.
- Nearly half of all adults with heart disease also have arthritis.
AM, et al. Managing cardiovascular disease risk in rheumatoid arthritis: clinical updates and three strategic approaches. Current Rheumatology Reports. 2017; 19(4):16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789778/
O, et al. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Annals of the Rheumatic Diseases. 2017; 76(8):1396-1404. https://www.ncbi.nlm.nih.gov/pubmed/28219882
Khalid U, et al. Incident heart failure in patients with rheumatoid arthritis: A nationwide cohort study. Journal of the American Heart Association. 2018;7:e007227. https://www.ahajournals.org/doi/10.1161/JAHA.117.007227
NJ, et al. Association of gout with long-term cardiovascular outcomes among patients with obstructive coronary artery disease. Journal of the American Heart Association. 2018;7:e009328. https://www.ahajournals.org/doi/10.1161/JAHA.118.009328
Wang H, et al. Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies. Scientific Reports. 2016; 6:39672. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177921/
Arts EE et al. Low disease activity (DAS28<3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study. Annals of the Rheumatic Diseases. 2017; 76(10):1693-1699. https://www.ncbi.nlm.nih.gov/pubmed/28606965
C, et al. The effects of tumor necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Annals of the Rheumatic Diseases. https://ard.bmj.com/content/74/3/480.
A, et al. Methotrexate and cardiovascular protection: Current evidence and future directions. Clinical Medicine Insights: Therapeutics. 2017. https://journals.sagepub.com/doi/full/10.1177/1179559X17741289
L, et al. Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2015. https://ard.bmj.com/content/75/12/2087.
U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. https://www.fda.gov/Drugs/DrugSafety/ucm451800.htm
CS, et al. Rheumatoid arthritis and cardiovascular disease. American Heart Journal. 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890244/
CDC: Comorbidities. https://www.cdc.gov/arthritis/data_statistics/comorbidities.htm
Stay in the Know. Live in the Yes.
Join the Live Yes! Arthritis Network. Tell us a little about yourself and you will receive emails packed with the latest information and resources to live your best life and connect with others.